奋乃静
抗精神病药
精神分裂症(面向对象编程)
精神科
精神病
医学
精神药理学
心理学
麻醉
作者
Michael R Hower,Surya Kumar Karlapati,Anil Bachu
出处
期刊:Cureus
[Cureus, Inc.]
日期:2024-01-03
摘要
Antipsychotics are considered a gold standard treatment for schizophrenia. However, there is considerable variation in antipsychotic medication choice. Factors considered involved include symptomatology, prior response, and adverse reactions. This case report presents a 38-year-old male patient with schizophrenia in acute psychosis refractory to several antipsychotics. Hypotheses for the mechanism of action of antipsychotics and psychopharmacology are discussed, and treatment resistance is defined. The patient’s psychiatric, medical, and social history and past antipsychotic medications are reviewed. Afterward, the rationale for initiating perphenazine is discussed, and the patient’s improvement with this medication is examined. Current literature on perphenazine’s efficacy is also reviewed and discussed alongside its limitations.
科研通智能强力驱动
Strongly Powered by AbleSci AI